These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2414308)

  • 1. A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens.
    McCullough KC; Crowther JR; Butcher RN
    J Virol Methods; 1985 Aug; 11(4):329-38. PubMed ID: 2414308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot-and-mouth disease virus typing by complement fixation and enzyme-linked immunosorbent assay using monovalent and polyvalent antisera.
    Alonso A; Martins MA; Gomes Mda P; Allende R; Söndahl MS
    J Vet Diagn Invest; 1992 Jul; 4(3):249-53. PubMed ID: 1325192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.
    Ouldridge EJ; Barnett PV; Parry NR; Syred A; Head M; Rweyemamu MM
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():203-7. PubMed ID: 6198448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The standardization of a 'spot-test' ELISA for the rapid screening of sera and hybridoma cell products II. The determination of binding capacity, binding ratio and coefficient of variation of different ELISA plates in sandwich and indirect ELISA.
    McCullough KC; Parkinson D
    J Biol Stand; 1984 Jan; 12(1):75-86. PubMed ID: 6321511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA.
    Hamblin C; Barnett IT; Hedger RS
    J Immunol Methods; 1986 Oct; 93(1):115-21. PubMed ID: 3021854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of inactivated foot-and-mouth disease virus antigen in liquid-phase blocking ELISA.
    Ferris NP; Kitching RP; Oxtoby JM; Philpot RM; Rendle R
    J Virol Methods; 1990 Jul; 29(1):33-41. PubMed ID: 2170435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A micro-enzyme-lavelled immunosorbent assay (MICORELISA) for the detection of foot-and-mouth disease virus antigen and antibody.
    Rai A; Lahiri DK
    Acta Virol; 1981 Jan; 25(1):49-52. PubMed ID: 6112866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a logistic model for the quantitative interpretation of indirect sandwich enzyme labelled immunosorbent assays (ELISA) for antibodies and antigens in foot and mouth disease.
    Hingley PJ; Ouldridge EJ
    Comput Biol Med; 1985; 15(3):137-52. PubMed ID: 2988859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid-phase blocking sandwich enzyme-linked immunosorbent assay for detection of antibodies against foot-and-mouth disease virus in water buffalo sera.
    Araújo JP; Montassier HJ; Pinto AA
    Am J Vet Res; 1996 Jun; 57(6):840-3. PubMed ID: 8725810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
    Butchaiah G; Rao BU
    Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies against foot-and-mouth disease virus using a liquid-phase blocking sandwich ELISA (LPBE) with a bioengineered 3D protein.
    O'Donnell VK; Boyle DB; Sproat K; Fondevila NA; Forman A; Schudel AA; Smitsaart EN
    J Vet Diagn Invest; 1996 Apr; 8(2):143-50. PubMed ID: 8744733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in antibody reactivity with foot-and-mouth disease virus (FMDV) 146S antigen before and after binding to a solid phase or complexing with specific antibody.
    McCullough KC; Crowther JR; Butcher RN
    J Immunol Methods; 1985 Sep; 82(1):91-100. PubMed ID: 2993421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An indirect sandwich enzyme labelled immunosorbent assay for the detection of foot and mouth disease virus immunizing antigen in tissue culture harvests.
    Ouldridge EJ; Barnett PV; Hingley PJ; Rweyemamu MM
    J Biol Stand; 1984 Oct; 12(4):339-51. PubMed ID: 6098580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzyme-linked immunosorbent assay (ELISA) for the primary diagnosis of foot-and-mouth disease. Characterization and comparison with complement fixation.
    Have P; Lei JC; Schjerning-Thiesen K
    Acta Vet Scand; 1984; 25(2):280-96. PubMed ID: 6095628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitopes on foot-and-mouth disease virus particles. I. Topology.
    McCullough KC; Crowther JR; Carpenter WC; Brocchi E; Capucci L; De Simone F; Xie Q; McCahon D
    Virology; 1987 Apr; 157(2):516-25. PubMed ID: 2435060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies.
    Van Maanen C; Terpstra C
    Biologicals; 1990 Oct; 18(4):315-9. PubMed ID: 2178351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative between-laboratory trials of the liquid-phase blocking sandwich ELISA for the detection of antibodies to foot-and-mouth disease virus.
    Psikal I; Zendulková D; Franz J; Lencuchová L; Ferris NP
    Vet Med (Praha); 1995; 40(1):1-5. PubMed ID: 7716862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.